Jiang Shao-Yun, Zou Yuan-Yuan, Wang Jian-Tao
School of Dentistry, Tianjin Medical University, Tianjin, China.
Mol Vis. 2012;18:2096-106. Epub 2012 Jul 26.
In our previous study, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) played a neuroprotective role in retinal ischemia/reperfusion (I/R) injury in rats. However, the mechanism of NF-κB neuroprotection is still unclear. We hypothesize that p38 mitogen-activated protein kinase (MAPK) is expressed and NF-κB activity induced by p38 MAPK plays a neuroprotective role through antiapoptotic genes (B-cell lymphoma [Bcl]-2 and Bcl-XL) in retinal cells in retinal I/R injury.
Retinal ischemia was induced by elevating intraocular pressure in rats. After retinal I/R, the p38 MAPK, NF-κB p65, Bcl-2, and Bcl-XL mRNA levels were measured with real-time polymerase chain reaction. NF-κB p65 activity was assessed with NF-κB enzyme-linked immunosorbent assay in retinal I/R injury and after application of the p38 MAPK inhibitor (SB203580). Furthermore, SB203580 and NF-κB p65 short interfering RNA (siRNA) were used in retinal I/R injury to examine the effects on Bcl-2 and Bcl-XL levels and nucleosome release in the retina and cell survival in the ganglion cell layer.
The mRNA levels of NF-κB p65 and p38 MAPK reached a peak at 6 h after retinal I/R and then decreased gradually. The mRNA levels of Bcl-2 and Bcl-XL significantly increased at 2, 4, and 6 h, peaked at 8 h, and decreased gradually, but remained at a higher level compared with the normal control, which was accompanied by an increase in NF-κB p65 in nuclear extracts. After application of SB203580, the increase in the NF-κB p65 levels in the nucleus induced with I/R was completely abolished, and the mRNA expression of Bcl-2 and Bcl-XL decreased significantly compared with the I/R controls. In addition, NF-κB p65 siRNA inhibited Bcl-2 and Bcl-XL expression. Inhibition of the p38 MAPK-NF-κB pathway (using SB203580 or NF-κB p65 siRNA) increased retinal nucleosome release and decreased the number of ganglion cells.
These findings provide evidence of crosstalk between p38 MAPK and NF-κB p65 and demonstrate a possible neuroprotective role for the p38 MAPK-NF-κB pathway through Bcl-2 and Bcl-XL in retinal I/R injury in rats.
在我们之前的研究中,活化B细胞核因子κB轻链增强子(NF-κB)在大鼠视网膜缺血/再灌注(I/R)损伤中发挥神经保护作用。然而,NF-κB神经保护的机制仍不清楚。我们推测p38丝裂原活化蛋白激酶(MAPK)表达,且由p38 MAPK诱导的NF-κB活性通过抗凋亡基因(B细胞淋巴瘤[Bcl]-2和Bcl-XL)在视网膜I/R损伤的视网膜细胞中发挥神经保护作用。
通过升高大鼠眼压诱导视网膜缺血。视网膜I/R后,用实时聚合酶链反应测量p38 MAPK、NF-κB p65、Bcl-2和Bcl-XL mRNA水平。在视网膜I/R损伤时以及应用p38 MAPK抑制剂(SB203580)后,用NF-κB酶联免疫吸附测定法评估NF-κB p65活性。此外,将SB203580和NF-κB p65小干扰RNA(siRNA)用于视网膜I/R损伤,以检查对视网膜中Bcl-2和Bcl-XL水平、核小体释放以及神经节细胞层细胞存活的影响。
视网膜I/R后6小时,NF-κB p65和p38 MAPK的mRNA水平达到峰值,然后逐渐下降。Bcl-2和Bcl-XL的mRNA水平在2、4和6小时显著升高,8小时达到峰值,然后逐渐下降,但与正常对照相比仍维持在较高水平,同时核提取物中的NF-κB p65增加。应用SB203580后,I/R诱导的细胞核中NF-κB p65水平的增加被完全消除,与I/R对照组相比,Bcl-2和Bcl-XL的mRNA表达显著降低。此外,NF-κB p65 siRNA抑制Bcl-2和Bcl-XL表达。抑制p38 MAPK-NF-κB途径(使用SB203580或NF-κB p65 siRNA)增加视网膜核小体释放并减少神经节细胞数量。
这些发现提供了p38 MAPK与NF-κB p65之间相互作用的证据,并证明p38 MAPK-NF-κB途径通过Bcl-2和Bcl-XL在大鼠视网膜I/R损伤中可能发挥神经保护作用。